Improved subthalamic nucleus depiction with quantitative susceptibility mapping

Radiology

Volumn 269, Issue 1, 2013, Pages 216-223

  Liu, Tian ^a   Eskreis Winkler, Sarah ^a   Schweitzer, Andrew D ^a   Chen, Weiwei ^a,b   Kaplitt, Michael G ^a   Tsiouris, A John ^a   Wang, Yi ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN MAPPING; BRAIN NUCLEUS; CAPSULA INTERNA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTRAST TO NOISE RATIO; FEMALE; GLOBUS PALLIDUS; HEALTH CARE QUALITY; HUMAN; IMAGE ANALYSIS; MAGNETISM; MALE; NERVE STIMULATOR; NEUROLOGIST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PATIENT REFERRAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; QUANTITATIVE SUSCEPTIBILITY MAPPING; SCORING SYSTEM; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SUSCEPTIBILITY WEIGHTED IMAGING; ZONA INCERTA;

ADULT; AGED; ALGORITHMS; DEEP BRAIN STIMULATION; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTHALAMIC NUCLEUS; YOUNG ADULT;

EID: 84880917980     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13121991     Document Type: Article

References (30)

1. Benabid AL, Chabardes S, Mitrofanis J, Pollak P. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol 2009;8(1):67-81.
2. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339(16):1105-1111. (Pubitemid 28465758)
3. Herzog J, Fietzek U, Hamel W, et al. Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease. Mov Disord 2004;19(9):1050-1054. (Pubitemid 39302837)
4. Guehl D, Cuny E, Benazzouz A, et al. Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors. Eur J Neurol 2006;13(9):963-971. (Pubitemid 44284903)
5. McIntyre CC, Mori S, Sherman DL, Thakor NV, Vitek JL. Electric field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus. Clin Neurophysiol 2004;115(3):589-595. (Pubitemid 38230986)
6. Tamma F, Caputo E, Chiesa V, et al. Anatomoclinical correlation of intraoperative stimulation-induced side-effects during HF-DBS of the subthalamic nucleus. Neurol Sci 2002;23(Suppl 2):S109-S110. (Pubitemid 35355800)
7. Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord 2006;21(Suppl 14):S171-S196. (Pubitemid 44028281)
8. Massey LA, Miranda MA, Zrinzo L, et al. High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage 2012;59(3):2035-2044.
9. Dormont D, Ricciardi KG, Tandé D, et al. Is the subthalamic nucleus hypointense on T2-weighted images? a correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol 2004;25(9):1516-1523. (Pubitemid 44383602)
10. Cho ZH, Min HK, Oh SH, et al. Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging. J Neurosurg 2010;113(3):639-647.
11. Schäfer A, Forstmann BU, Neumann J, et al. Direct visualization of the subthalamic nucleus and its iron distribution using highresolution susceptibility mapping. Hum Brain Mapp 2012;33(12):2831-2842.
12. Breit S, LeBas JF, Koudsie A, et al. Pretargeting for the implantation of stimulation electrodes into the subthalamic nucleus: a comparative study of magnetic resonance imaging and ventriculography. Neurosurgery 2006;58(1 Suppl):ONS83-ONS95.
13. de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med 2010;63(1):194-206.
14. Liu J, Liu T, de Rochefort L, et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012;59(3):2560-2568.
15. Liu T, Liu J, de Rochefort L, et al. Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging. Magn Reson Med 2011;66(3):777-783.
16. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011;54(4):2789-2807.
17. Volz S, Hattingen E, Preibisch C, Gasser T, Deichmann R. Reduction of susceptibilityinduced signal losses in multi-gradient-echo images: application to improved visualization of the subthalamic nucleus. Neuroimage 2009;45(4):1135-1143.
18. Wang Y, Yu Y, Li D, et al. Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging 2000;12(5):661-670.
19. Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn Reson Med 2008;60(5):1155-1168.
20. Liu T, Wisnieff C, Lou M, Chen W, Spincemaille P, Wang Y. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn Reson Med 2013;69(2):467-476.
21. Vertinsky AT, Coenen VA, Lang DJ, et al. Localization of the subthalamic nucleus: optimization with susceptibility-weighted phase MR imaging. AJNR Am J Neuroradiol 2009;30(9):1717-1724.
22. Gross RE, Krack P, Rodriguez-Oroz MC, Rezai AR, Benabid AL. Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor. Mov Disord 2006;21(Suppl 14):S259-S283. (Pubitemid 44028286)
23. Just M, Thelen M. Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. Radiology 1988;169(3):779-785.
24. Langkammer C, Schweser F, Krebs N, et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? a post mortem validation study. Neuroimage 2012;62(3):1593-1599.
25. Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 1987;149(2):365-379. (Pubitemid 17104998)
26. Li J, Chang S, Liu T, et al. Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping. Magn Reson Med 2012;68(5):1563-1569.
27. Lanotte MM, Rizzone M, Bergamasco B, Faccani G, Melcarne A, Lopiano L. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002;72(1):53-58. (Pubitemid 34073097)
28. O'Gorman RL, Shmueli K, Ashkan K, et al. Optimal MRI methods for direct stereotactic targeting of the subthalamic nucleus and globus pallidus. Eur Radiol 2011;21(1):130-136.
29. Liu T, Spincemaille P, de Rochefort L, Kressler B, Wang Y. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn Reson Med 2009;61(1):196-204.
30. Schweser F, Deistung A, Sommer K, Reichenbach JR. Toward online reconstruction of quantitative susceptibility maps: superfast dipole inversion. Magn Reson Med 2012 Jul 12. [Epub ahead of print]